{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T10:34:31Z","timestamp":1792838071649,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chongqing Key Laboratory of Birth Defects and Reproductive Health, Chongqing Population and Family Planning Science and Technology Research Institute","award":["2021yjy-kfkt-0008"],"award-info":[{"award-number":["2021yjy-kfkt-0008"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-023-07285-1","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T06:01:50Z","timestamp":1701324110000},"page":"679-688","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effect of GnRH agonist trigger with or without low-dose hCG on reproductive outcomes for PCOS women with freeze-all strategy: a propensity score matching study"],"prefix":"10.1007","volume":"309","author":[{"given":"Qiaofeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexue","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3486-1020","authenticated-orcid":false,"given":"Xiaojun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"7285_CR1","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1631\/jzus.B1700074","volume":"19","author":"FF Wang","year":"2018","unstructured":"Wang FF, Pan JX, Wu Y, Zhu YH, Hardiman PJ, Qu F (2018) American, European, and Chinese practice guidelines or consensuses of polycystic ovary syndrome: a comparative analysis. J Zhejiang Univ Sci B 19:354\u2013363","journal-title":"J Zhejiang Univ Sci B"},{"key":"7285_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.922044","volume":"13","author":"R Zeng","year":"2022","unstructured":"Zeng R, Chen H, Zeng X, Qin L (2022) The essential role of body weight in adjusting gn dosage to prevent high ovarian response for women with PCOS during IVF: a retrospective study. Front Endocrinol (Lausanne) 13:922044","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7285_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/humrep\/det015","volume":"28","author":"R Homburg","year":"2013","unstructured":"Homburg R, Ray A, Bhide P, Gudi A, Shah A, Timms P, Grayson K (2013) The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study. Hum Reprod 28:1077\u20131083","journal-title":"Hum Reprod"},{"key":"7285_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.615957","volume":"11","author":"B Sun","year":"2020","unstructured":"Sun B, Ma Y, Li L, Hu L, Wang F, Zhang Y, Dai S, Sun Y (2020) Factors associated with ovarian hyperstimulation syndrome (OHSS) severity in women with polycystic ovary syndrome undergoing IVF\/ICSI. Front Endocrinol (Lausanne) 11:615957","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7285_CR5","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1016\/j.fertnstert.2016.08.048","volume":"106","author":"S Pfeifer","year":"2016","unstructured":"Pfeifer S, Butts S, Dumesic D, Fossum G et al (2016) Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertil Steril 106:1634\u20131647","journal-title":"Fertil Steril"},{"key":"7285_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, Stener-Victorin E, Fauser BC, Norman RJ, Teede H (2016) The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update 22:687\u2013708","journal-title":"Hum Reprod Update"},{"key":"7285_CR7","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","volume":"2","author":"T Ovarian Stimulation","year":"2020","unstructured":"Ovarian Stimulation T, Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, Kunicki M, La Marca A, Lainas G et al (2020) 2020 ESHRE guideline: ovarian stimulation for IVF\/ICSI(\u2020). Hum Reprod Open 2:hoaa009","journal-title":"Hum Reprod Open"},{"key":"7285_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","volume":"23","author":"CB Lambalk","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, Toftager M, Pinborg A, Homburg R, van der Veen F, van Wely M (2017) GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update 23:560\u2013579","journal-title":"Hum Reprod Update"},{"key":"7285_CR9","doi-asserted-by":"publisher","unstructured":"Youssef MA, Van der Veen F, Al-Inany HG, Mochtar MH, Griesinger G, Nagi Mohesen M, Aboulfoutouh I, van Wely M 2014 Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. Cochrane Database Syst Rev (10):Cd008046. https:\/\/doi.org\/10.1002\/14651858.CD008046.pub4","DOI":"10.1002\/14651858.CD008046.pub4"},{"key":"7285_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.fertnstert.2015.01.012","volume":"103","author":"RF Casper","year":"2015","unstructured":"Casper RF (2015) Introduction: gonadotropin-releasing hormone agonist triggering of final follicular maturation for in vitro fertilization. Fertil Steril 103:865\u2013866","journal-title":"Fertil Steril"},{"key":"7285_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.fertnstert.2015.01.034","volume":"103","author":"P Humaidan","year":"2015","unstructured":"Humaidan P, Engmann L, Benadiva C (2015) Luteal phase supplementation after gonadotropin-releasing hormone agonist trigger in fresh embryo transfer: the American versus European approaches. Fertil Steril 103:879\u2013885","journal-title":"Fertil Steril"},{"key":"7285_CR12","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.fertnstert.2013.07.1976","volume":"100","author":"MH Lin","year":"2013","unstructured":"Lin MH, Wu FS, Lee RK, Li SH, Lin SY, Hwu YM (2013) Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril 100:1296\u20131302","journal-title":"Fertil Steril"},{"key":"7285_CR13","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10815-016-0755-8","volume":"33","author":"KE O'Neill","year":"2016","unstructured":"O\u2019Neill KE, Senapati S, Maina I, Gracia C, Dokras A (2016) GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone. J Assist Reprod Genet 33:1175\u20131184","journal-title":"J Assist Reprod Genet"},{"key":"7285_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12884-022-04499-0","volume":"22","author":"Y He","year":"2022","unstructured":"He Y, Tang Y, Chen S, Liu J, Liu H (2022) Effect of GnRH agonist alone or combined with different low-dose hCG on cumulative live birth rate for high responders in GnRH antagonist cycles: a retrospective study. BMC Pregnancy Childbirth 22:172","journal-title":"BMC Pregnancy Childbirth"},{"key":"7285_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.15537\/smj.2017.6.17717","volume":"38","author":"M Karacan","year":"2017","unstructured":"Karacan M, Erdem E, Usta A, Arvas A, Cebi Z, Camlibel T (2017) Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders. Saudi Med J 38:586\u2013591","journal-title":"Saudi Med J"},{"key":"7285_CR16","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1093\/humrep\/deaa226","volume":"35","author":"S Santos-Ribeiro","year":"2020","unstructured":"Santos-Ribeiro S, Mackens S, Popovic-Todorovic B, Racca A, Polyzos NP, Van Landuyt L, Drakopoulos P, de Vos M, Tournaye H, Blockeel C (2020) The freeze-all strategy versus agonist triggering with low-dose hCG for luteal phase support in IVF\/ICSI for high responders: a randomized controlled trial. Hum Reprod 35:2808\u20132818","journal-title":"Hum Reprod"},{"key":"7285_CR17","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.fertnstert.2019.08.009","volume":"112","author":"M Qiu","year":"2019","unstructured":"Qiu M, Tao Y, Kuang Y, Wang Y (2019) Effect of body mass index on pregnancy outcomes with the freeze-all strategy in women with polycystic ovarian syndrome. Fertil Steril 112:1172\u20131179","journal-title":"Fertil Steril"},{"key":"7285_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.fertnstert.2007.02.002","volume":"89","author":"L Engmann","year":"2008","unstructured":"Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C (2008) The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89:84\u201391","journal-title":"Fertil Steril"},{"key":"7285_CR19","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.fertnstert.2009.10.034","volume":"94","author":"AJ DiLuigi","year":"2010","unstructured":"DiLuigi AJ, Engmann L, Schmidt DW, Maier DB, Nulsen JC, Benadiva CA (2010) Gonadotropin-releasing hormone agonist to induce final oocyte maturation prevents the development of ovarian hyperstimulation syndrome in high-risk patients and leads to improved clinical outcomes compared with coasting. Fertil Steril 94:1111\u20131114","journal-title":"Fertil Steril"},{"key":"7285_CR20","doi-asserted-by":"publisher","first-page":"2180933","DOI":"10.1155\/2021\/2180933","volume":"2021","author":"X Shen","year":"2021","unstructured":"Shen X, Yang Q, Li L, Lu W (2021) Clinical pregnancy and incidence of ovarian hyperstimulation syndrome in high ovarian responders receiving different doses of hCG supplementation in a GnRH-agonist trigger protocol. Evid Based Complement Alternat Med 2021:2180933","journal-title":"Evid Based Complement Alternat Med"},{"key":"7285_CR21","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.fertnstert.2015.06.011","volume":"104","author":"L Meyer","year":"2015","unstructured":"Meyer L, Murphy LA, Gumer A, Reichman DE, Rosenwaks Z, Cholst IN (2015) Risk factors for a suboptimal response to gonadotropin-releasing hormone agonist trigger during in vitro fertilization cycles. Fertil Steril 104:637\u2013642","journal-title":"Fertil Steril"},{"key":"7285_CR22","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.rbmo.2015.12.007","volume":"32","author":"L Engmann","year":"2016","unstructured":"Engmann L, Benadiva C, Humaidan P (2016) GnRH agonist trigger for the induction of oocyte maturation in GnRH antagonist IVF cycles: a SWOT analysis. Reprod Biomed Online 32:274\u2013285","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"7285_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81(1):19\u201325. https:\/\/doi.org\/10.1016\/j.fertnstert.2003.10.004","journal-title":"Fertil Steril"},{"issue":"6","key":"7285_CR24","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/humrep\/der037","volume":"26","author":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology","year":"2011","unstructured":"Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology (2011) The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting. Hum Reprod 26(6):1270\u20131283. https:\/\/doi.org\/10.1093\/humrep\/der037","journal-title":"Hum Reprod"},{"key":"7285_CR25","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0015-0282(00)00518-5","volume":"73","author":"DK Gardner","year":"2000","unstructured":"Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB (2000) Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril 73:1155\u20131158","journal-title":"Fertil Steril"},{"key":"7285_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/00006254-198906000-00004","volume":"44","author":"A Golan","year":"1989","unstructured":"Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E (1989) Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44:430\u2013440","journal-title":"Obstet Gynecol Surv"},{"key":"7285_CR27","first-page":"738","volume":"58","author":"Capital Institute of Pediatrics, & Coordinating Study Group of Nine Cities on the Physical Growth and Development of Children","year":"2020","unstructured":"Capital Institute of Pediatrics, & Coordinating Study Group of Nine Cities on the Physical Growth and Development of Children (2020) Growth standard curves of birth weight, length and head circumference of Chinese newborns of different gestation. Zhonghua Er Ke Za Zhi 58:738\u2013746","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"7285_CR28","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1111\/1475-6773.12182","volume":"49","author":"MM Garrido","year":"2014","unstructured":"Garrido MM, Kelley AS, Paris J, Roza K, Meier DE, Morrison RS, Aldridge MD (2014) Methods for constructing and assessing propensity scores. Health Serv Res 49:1701\u20131720","journal-title":"Health Serv Res"},{"key":"7285_CR29","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.fertnstert.2020.04.004","volume":"114","author":"DA Schirmer 3rd","year":"2020","unstructured":"Schirmer DA 3rd, Kulkarni AD, Zhang Y, Kawwass JF, Boulet SL, Kissin DM (2020) Ovarian hyperstimulation syndrome after assisted reproductive technologies: trends, predictors, and pregnancy outcomes. Fertil Steril 114:567\u2013578","journal-title":"Fertil Steril"},{"key":"7285_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.repbio.2017.01.004","volume":"17","author":"C Dosouto","year":"2017","unstructured":"Dosouto C, Haahr T, Humaidan P (2017) Gonadotropin-releasing hormone agonist (GnRHa) trigger-State of the art. Reprod Biol 17:1\u20138","journal-title":"Reprod Biol"},{"key":"7285_CR31","first-page":"48","volume":"25","author":"K Deepika","year":"2021","unstructured":"Deepika K, Suvarna R, Sumi M, Snehal D, Arveen V, Anuja K, Gautham P, Kamini R (2021) HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes. JBRA Assist Reprod 25:48\u201358","journal-title":"JBRA Assist Reprod"},{"key":"7285_CR32","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/0974-1208.192056","volume":"9","author":"D Krishna","year":"2016","unstructured":"Krishna D, Dhoble S, Praneesh G, Rathore S, Upadhaya A, Rao K (2016) Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: a Randomized control trial. J Hum Reprod Sci 9:164\u2013172","journal-title":"J Hum Reprod Sci"},{"key":"7285_CR33","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/j.fertnstert.2012.03.015","volume":"97","author":"D Griffin","year":"2012","unstructured":"Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L (2012) Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril 97:1316\u20131320","journal-title":"Fertil Steril"},{"key":"7285_CR34","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.1016\/j.fertnstert.2011.03.109","volume":"95","author":"BS Shapiro","year":"2011","unstructured":"Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C (2011) Comparison of \u201ctriggers\u201d using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. Fertil Steril 95:2715\u20132717","journal-title":"Fertil Steril"},{"key":"7285_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1080\/14647273.2019.1671614","volume":"24","author":"BP Jones","year":"2021","unstructured":"Jones BP, Al-Chami A, Gonzalez X, Arshad F, Green J, Bracewell-Milnes T, Saso S, Smith R, Serhal P, Ben Nagi J (2021) Is oocyte maturity influenced by ovulation trigger type in oocyte donation cycles? Hum Fertil (Camb) 24:360\u2013366","journal-title":"Hum Fertil (Camb)"},{"key":"7285_CR36","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10815-019-01646-z","volume":"37","author":"R Makhijani","year":"2020","unstructured":"Makhijani R, Thorne J, Bartels C, Bartolucci A, Nulsen J, Grow D, Benadiva C, Engmann L (2020) Pregnancy outcomes after frozen-thawed single euploid blastocyst transfer following IVF cycles using GNRH agonist or HCG trigger for final oocyte maturation. J Assist Reprod Genet 37:611\u2013617","journal-title":"J Assist Reprod Genet"},{"key":"7285_CR37","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/humrep\/deaa042","volume":"35","author":"BL Maslow","year":"2020","unstructured":"Maslow BL, Guarnaccia M, Stefanacci C, Ramirez L, Klein JU (2020) The use of GnRH-agonist trigger for the final maturation of oocytes in normal and low responders undergoing planned oocyte cryopreservation. Hum Reprod 35:1054\u20131060","journal-title":"Hum Reprod"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07285-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-07285-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-07285-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,24]],"date-time":"2024-01-24T18:06:15Z","timestamp":1706119575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-07285-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":37,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["7285"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-07285-1","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"11 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed in accordance with the ethical standards of the Declaration of Helsinki (1964) and its subsequent amendments. The study protocol involved human participants were approved by the Ethics Committee of Chongqing Medical University (number: 2021060).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the retrospective nature, written informed consent was waived by the Ethics Committee of Chongqing Medical University.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}